534 Participants Needed

Whole vs Reduced-Fat Milk for Childhood Obesity

(CoMFORT Trial)

JL
Overseen ByJonathon L Maguire, MD, FRCPC
Age: < 18
Sex: Any
Trial Phase: Academic
Sponsor: The Hospital for Sick Children
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

What You Need to Know Before You Apply

What is the purpose of this trial?

Cow's milk is a dietary staple for children in North America. Though clinical guidelines suggest children transition from whole (3.25% fat) milk to reduced (1%) fat milk at age 2 years, recent epidemiological evidence supports a link between whole milk consumption and lower adiposity in children. The purpose of this trial is to determine which milk fat recommendation minimizes excess adiposity and optimizes child nutrition and development. CoMFORT will be a parallel group randomized controlled trial among children aged 2 to 4 years participating in the TARGet Kids! practice-based research network. Children will be randomized to receive one of two usual care nutritional recommendations: 1) a recommendation to consume whole milk, or 2) a recommendation to consume reduced (1%) fat milk. The primary outcome is Body Mass Index z-score (zBMI); secondary outcomes will be cognitive development (using the Ages and Stages Questionnaire), vitamin D stores (serum 25-hydroxyvitamin D), cardiometabolic health (glucose, hsCRP, non-HDL, LDL, triglyceride, HDL and total cholesterol, insulin, and diastolic and systolic blood pressure) and sugar sweetened beverage intake (measured by 24-hour dietary recall). Outcomes will be measured 24 months post-randomization and compared using ANCOVA, adjusting for baseline measures. This trial will contribute to nutrition policy for children in effort to reduce childhood obesity using a simple, inexpensive and scalable cow's milk fat intervention.

Will I have to stop taking my current medications?

The trial information does not specify whether participants need to stop taking their current medications.

Is it safe for children to consume whole or reduced-fat milk?

Research suggests that both whole and reduced-fat milk are generally safe for children. However, guidelines recommend whole milk for children under 2 years and reduced-fat milk for older children to help manage obesity risk. Nutrient intake is similar between the two, except for fat content.12345

How does the treatment of recommending reduced-fat or whole milk differ from other treatments for childhood obesity?

This treatment is unique because it focuses on the type of milk fat consumed by children, with recent evidence suggesting that whole milk might be linked to lower obesity rates compared to reduced-fat milk, challenging traditional guidelines that recommend low-fat options to prevent obesity.12346

What data supports the effectiveness of the treatment of different milk fat recommendations for childhood obesity?

Recent studies suggest that consuming whole fat dairy products, like whole milk, may help protect against severe obesity in children, as seen in a study of Latino children where those who consumed more milk fat were less likely to be severely obese.12346

Who Is on the Research Team?

JL

Jonathon L Maguire, MD, FRCPC

Principal Investigator

Unity Health Toronto

Are You a Good Fit for This Trial?

This trial is for healthy children aged 1.5 to almost 3 years who are part of the TARGet Kids! network, can communicate in English or French, and regularly consume cow's milk. It excludes those with certain medical conditions like Prader-Willi syndrome, severe developmental delays, lactose intolerance or allergy to cow's milk.

Inclusion Criteria

I am between 1.5 and 3 years old.
involved in a TARGet Kids! academic pediatric or family medicine group
healthy by parental report

Exclusion Criteria

Siblings of trial participants are not allowed to participate because families may share milk.
You have a significant delay in your development.
You have a medical condition that causes obesity, such as Prader-Willi syndrome or other similar syndromes.
See 2 more

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Treatment

Children are randomized to receive either whole milk or reduced fat milk as part of their usual care nutritional recommendations

24 months

Follow-up

Participants are monitored for safety and effectiveness after treatment

4 weeks

What Are the Treatments Tested in This Trial?

Interventions

  • Reduced (1%) fat milk
  • Whole (3.25%) cow's milk recommendation
Trial Overview The CoMFORT study tests whether whole (3.25% fat) or reduced (1% fat) cow's milk affects childhood obesity over a two-year period. Children will be randomly assigned to one of these two dietary recommendations and their growth, cognitive development, vitamin D levels, heart health markers and diet will be monitored.
How Is the Trial Designed?
2Treatment groups
Active Control
Group I: Whole (3.25%) milkActive Control1 Intervention
Group II: Reduced fat (1%) milkActive Control1 Intervention

Reduced (1%) fat milk is already approved in Canada, United States for the following indications:

🇨🇦
Approved in Canada as Reduced-fat milk for:
🇺🇸
Approved in United States as Reduced-fat milk for:

Find a Clinic Near You

Who Is Running the Clinical Trial?

The Hospital for Sick Children

Lead Sponsor

Trials
724
Recruited
6,969,000+

Unity Health Toronto

Collaborator

Trials
572
Recruited
470,000+

Published Research Related to This Trial

Physicians and parents have differing recommendations and practices regarding cow's milk fat for 2-year-old children, with 36% of parents providing whole milk and 58% offering reduced-fat milk.
Qualitative interviews revealed that both groups have mixed views on the role of cow's milk fat in children's diets, highlighting a need for clearer guidance on its impact on child obesity to support informed dietary choices.
A qualitative study to understand parent and physician perspectives about cow's milk fat for children.Vanderhout, SM., Juando-Prats, C., Birken, CS., et al.[2023]
The Cow's Milk Fat Obesity pRevention Trial will involve 534 children aged 2 to 4-5 years to compare the effects of whole milk versus reduced fat milk on body fat and overall health over 24 months.
This study aims to provide evidence on whether whole milk can help minimize excess body fat and improve nutrition in children, potentially influencing future dietary guidelines to combat childhood obesity.
Cow's Milk Fat Obesity pRevention Trial (CoMFORT): a primary care embedded randomised controlled trial protocol to determine the effect of cow's milk fat on child adiposity.Vanderhout, SM., Aglipay, M., Birken, C., et al.[2023]
In a study of 145 Latino preschoolers, higher consumption of milk fat was linked to lower odds of severe obesity, suggesting that whole fat dairy may be protective against obesity in this population.
Severely obese children consumed less milk fat (5.3 g) compared to their non-severely obese peers (8.9 g), indicating that promoting lower fat milk may not be beneficial for preventing obesity in young children.
Full fat milk consumption protects against severe childhood obesity in Latinos.Beck, AL., Heyman, M., Chao, C., et al.[2023]

Citations

A qualitative study to understand parent and physician perspectives about cow's milk fat for children. [2023]
Cow's Milk Fat Obesity pRevention Trial (CoMFORT): a primary care embedded randomised controlled trial protocol to determine the effect of cow's milk fat on child adiposity. [2023]
Full fat milk consumption protects against severe childhood obesity in Latinos. [2023]
Whole milk compared with reduced-fat milk and childhood overweight: a systematic review and meta-analysis. [2023]
Cow's milk fat and child adiposity: a prospective cohort study. [2022]
Feeding low-fat milk during infancy. [2015]
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Terms of Service·Privacy Policy·Cookies·Security